Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Cash from Operations (2016 - 2025)

Utah Medical Products has reported Cash from Operations over the past 16 years, most recently at 3477000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 3477000.0 for Q4 2025, up 18.39% from a year ago — trailing twelve months through Dec 2025 was 14692000.0 (down 0.94% YoY), and the annual figure for FY2025 was 14692000.0, down 0.94%.
  • Cash from Operations for Q4 2025 was 3477000.0 at Utah Medical Products, down from 3878000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for UTMD hit a ceiling of 6915000.0 in Q1 2023 and a floor of 2762000.0 in Q2 2024.
  • Median Cash from Operations over the past 5 years was 4950000.0 (2021), compared with a mean of 4707700.0.
  • Biggest five-year swings in Cash from Operations: surged 37.04% in 2023 and later crashed 44.92% in 2024.
  • Utah Medical Products' Cash from Operations stood at 4987000.0 in 2021, then grew by 13.9% to 5680000.0 in 2022, then dropped by 6.13% to 5332000.0 in 2023, then crashed by 44.92% to 2937000.0 in 2024, then rose by 18.39% to 3477000.0 in 2025.
  • The last three reported values for Cash from Operations were 3477000.0 (Q4 2025), 3878000.0 (Q3 2025), and 2873000.0 (Q2 2025) per Business Quant data.